iRadPulse

🚨 Anticoagulant use after EVAR linked to 3.79x higher risk of prosthetic limb occlusion, compared to antiplatelet therapy (APT) users 👇 Dive into this newly published paper from CardioVascular and Interventional Radiology (CVIR) examining antithrombotic strategies post-EVAR Study Methods: 🔍 Retrospective single-center cohort 🔍 616 patients undergoing elective EVAR 🔍 Groups: Single APT (n=450), anticoagulants (n=84), double APT (n=82) 📅 Median follow-up: ~4 years Key outcomes: MACE, prosthetic limb occlusion, bleeding complications Key Findings: 🫀 No significant difference in MACE incidence between groups (log-rank p=0.37) 🦵 Prosthetic limb occlusion: 𝑝<0.01 for anticoagulant use; other therapies not significantly different 🩸 Bleeding risks similar across groups (log-rank p=0.06) Predictors: 👤 Age and ASA classification significant for MACE 🧬 Age and anticoagulant use significant for prosthetic limb occlusion 🔍 ASA classification impacts bleeding risk 📌 Conclusion: In this study, anticoagulants increased prosthetic limb occlusion risk post-EVAR compared to antiplatelet therapies. Aging & ASA class influenced cardiovascular events. Dive into the full study: https://lnkd.in/evvQ8TEn What are your thoughts? Daphne van der Veen Michiel Warlé Stay ahead in #VascularHealth by using #AI! Subscribe to our newsletter: https://lnkd.in/gRwAjsEf #VIR #iRads #InterventionalRadiology #RiskStratification #Research #Cardiology #Vascular #VascularSurgery #EVAR #Antithrombotic Endovascular Today CVIR Endovascular Cardiovascular and Interventional Radiological Society of Europe (CIRSE)

🚨 96.4% technical success rate in robotic-assisted needle insertions for bone procedures! This study explores a new robotic application for safe and precise percutaneous interventions👇 Discover the innovative findings from JVIR Media Key Focus: Evaluating the feasibility and safety of a modified robotic device in needle insertions for bone Study involved 6 radiologists using robotic guidance on 3 pigs under general anesthesia Results: 🔹 28 needle insertions: 10 spine, 18 pelvis 🔹 96.4% technical success rate 🔹 No severe complications 🔹 Placement success hit a perfect 100% (27/27) 🔹 Mean lateral deviation of 2.1 mm (±1.3) 🔹 40.7% of trajectories needed only one modification Performance Insights: 🔹 48.1% of trajectories needed no changes post-CT scan 🔹 Individual modification strategies allowed 🔹 All procedures were complication-free The future of precision needle placement looks promising! 📌 Conclusion: In this study, robotic-assisted needle insertion in bone procedures demonstrated potential safety and accuracy with a promising pre-clinical success mode Dive deeper into this cutting-edge study! ➡️ https://lnkd.in/eCXZ3_B5 What are your thoughts on this approach? Laurent Milot William Boulade Lambros TSELIKAS Charles Mastier Thierry De Baere Alexandre GALAN Nicolas Stacoffe IRs using #AI will replace those who don’t! Save time, get smarter, & become AI enhanced! Be sure to subscribe to our newsletter: https://lnkd.in/gRwAjsEf #VIR #iRads #MedicalInnovation #MinimallyInvasive #InterventionalRadiology #RobotAssistedSurgery #BoneHealth #Orthopedics #Radiology #RoboticAssistance #Robotics

🚨 In patients with recurrent portal hypertension (PH) after liver transplant (LT), TIPS resulted in ascites resolution in 74%👇 Dive into this new study from JVIR Media exploring the impact of TIPS on outcomes for recurrent PH Study Overview: - 1846 liver transplant recipients analyzed - 36 (2%) underwent TIPS post-transplant - Control group: 381 LT patients selected - Recurrent PH detected via diuretic refractory ascites & endoscopic findings Key Findings: - Ascites resolution in 74% of TIPS patients - Repeat transplant less frequent in TIPS group vs. non-TIPS (11% vs 33%, p=0.035) - Median survival post-TIPS: 2.4 years Additional Insights: - No significant difference in transplant-free survival: 8.6 years (TIPS) vs. 7.6 years (non-TIPS), (p=0.360) - Multivariable Cox analysis: Repeat transplant linked to reduced mortality (HR=0.15, p=0.016) 📌 Conclusion: In this cohort, TIPS placement in patients with recurrent PH after LT was associated with a 74% resolution of ascites and comparable transplant-free survival relative to controls. Full study: https://lnkd.in/eKxAAJbG What are your thoughts on this approach? Nassir Rostambeigi Michael Darcy Steven Sauk IRs using #AI will replace those who don’t! Save time, get smarter, & become AI enhanced! Subscribe to our newsletter: https://lnkd.in/gRwAjsEf #VIR #iRads #InnovativeCare #Hepatology #SurvivalAnalysis #Radiology #MedicalResearch #MedTwitter #LiverDisease #PatientCare #IR #Gastroenterology #Hepatology #LiverTransplant #TIPS Society of Interventional Radiology Mallinckrodt Institute of Radiology

🚨 IVUS-guided TIPS reduced hospital stays by nearly a day but led to a net cost increase of $1,484.96 per case👇 Check out this new study from JVIR Media comparing IVUS-guided vs non-IVUS-guided TIPS! Study Focus: Costs and resource utilization of IVUS-guided vs non-IVUS-guided TIPS 🔍 157 patients: 91 IVUS-guided, 66 non-IVUS 🔍 Compared procedure times, contrast use, staffing, meds, and equipment Key Findings: ⏱️ IVUS-guided TIPS creation: • 45.5 min faster (p<0.001) • 35.2 mL less contrast material (p<0.001) • Savings: $325.34 staffing, $58.21 meds, $76.59 equipment Cost Analysis: 💸 IVUS single-use catheter adds $2,100 💰 Despite speeding TIPS, costs increase per procedure by $1,484.96 🏥 Hospital stay impact: • IVUS: 1.3 days mean stay • Non-IVUS: 2.1 days mean stay (p=0.001) • Saving $656.64 overall 📌 Conclusion: This study found that IVUS-guided TIPS reduced hospital stays by nearly a day and improved efficiency, but the added catheter cost led to a net increase of $1,484.96 per procedure. Explore the full study: https://lnkd.in/efbRDuN2 What are your thoughts on integrating IVUS for TIPS? James Ronald Jonathan Martin Charles Kim Chauncy Handran Brian Triana, MD, MBA Abby Britt Follow us to keep up-to-date with the latest in #VIR #iRads and subscribe to our newsletter: https://lnkd.in/gRwAjsEf #IRcommunity #MedicalResearch #CostSavings #PatientOutcomes #Hepatology #TIPS #MedTwitter #Radiology #TimeEfficiency #CostAnalysis #InterventionalRadiology #TIPS #Hepatology #InterventionalRadiology Society of Interventional Radiology

🚨 3D-printed vascular model training boosts skills in experienced interventional radiologists! 📈🩺 👇 Explore the latest study from JVIR Media on enhancing advanced catheterization skills with innovative simulation training Study Details: 🔍 Focused on 2 patient-specific 3D-printed models with complex celiac axis anatomy 🔍 Evaluated with the Global Rating Scale of Endovascular Performance (GRS-EP) 🔍 5 experienced IRs participated Key Findings: ✨ Success rate, insertion time, and GRS-EP scores improved post-training ✨ High inter-rater reliability confirmed ✨ Notably, both video and self-evaluation scores saw a significant rise 📌 Conclusion: While direct correlation to human performance remains unproven, 3D simulation training shows promise in skill refinement for experienced IRs. Read the full study here: https://lnkd.in/gj7Ug364 What are your thoughts on this approach? Kohsuke Kudo IRs using #AI will replace those who don’t! Save time, get smarter, & become AI enhanced! Be sure to subscribe our newsletter: https://lnkd.in/gRwAjsEf #VIR #iRads #SimulationTraining #IRAdvancement #RadiologyResearch #MedicalInnovation #TrainingEffectiveness #EndovascularSkills #VascularIR #SimulationTraining #InterventionalRadiology #MedicalEducation

🚨 92.8% of aneurysmal bone cysts were inactive after 24 months post-treatment with radio-opaque gelified ethanol sclerotherapy!👇 Newly published study from CardioVascular and Interventional Radiology (CVIR) on the innovative approach to tackling these aggressive lesions 📚🩺 Study Overview: 🔍 Single-center, retrospective study 🔍 27 patients treated (primary aneurysmal bone cysts) 🔍 Percutaneous sclerotherapy with radio-opaque gelified ethanol 🔍 Evaluated safety and effectiveness Key Findings: ✅ No major complications ✅ Minor complication rate: 3.7% (resolved with antibiotics) ✅ No post-sclerotherapy fractures ✅ Surgical revision needed for 7.4% of cases (2 patients) 📈 Favorable clinical/radiological outcomes across the cohort Success Rates: 🎯 77.8% inactive at 12 months 🎯 92.8% inactive at 24 months 🎯 100% inactive at 36+ months 📌 Conclusion: This study found that percutaneous sclerotherapy with radio-opaque gelified ethanol is a promising minimally invasive option for treating primary aneurysmal bone cysts. Full study available here: https://lnkd.in/e5EStxNX What are your thoughts on this approach? Sylvain Grange Nicolas Stacoffe Rémi GRANGE Valentin Gineys Follow us for the latest in #VIR and subscribe to our newsletter for more insights: https://lnkd.in/gRwAjsEf #BoneCyst #InterventionalRadiology #MusculoskeletalHealth #InnovativeTherapies #ClinicalSuccess #RadiologySuccess #Orthopedics #PatientSafety #BoneHealth #RadOnc #Musculoskeletal #Intervention #BoneCysts #Sclerotherapy CVIR Endovascular Cardiovascular and Interventional Radiological Society of Europe (CIRSE)

🚨 Did you know? Using resin Yttrium-90 transarterial radioembolization (Y90-TARE), 33% of HCC patients were downstaged, enabling resection! 👇 Discover insights from this new CardioVascular and Interventional Radiology (CVIR) study on managing HCC with vascular invasion Study Overview: This retrospective study analyzed 34 HCC patients with vascular invasion treated with resin Y90-TARE from 2014-2022 Patients with main portal vein invasion and ECOG 2 were excluded Let's delve into the key results! 🏥 Results: - Objective response rate at 6 months: 67% - Disease control rate: 72% - Median survival: 18 months; progression-free survival: 9.8 months - 1-yr and 3-yr survival rates for >180 Gy: 76% and 57%; <180 Gy: 29% and 15% (p=0.01) Key Findings: - 33% of Child-Pugh A patients (ECOG < 1) downstaged to resection - Complete pathologic necrosis in 40% of these patients - 1-yr and 3-yr survival post-resection: 100% - Low adverse events: Grade-3 in 15%, no grade-4 or 5 📌 Conclusion: Resin Y90-TARE with the single-compartment MIRD model shows promise in downstaging HCC with segmental and lobar invasion, especially with doses >180 Gy Read the full study: https://lnkd.in/eg3-_rQq What are your thoughts? Muneeb Ahmed Ammar Sarwar Jeff Weinstein Devin E. Eckhoff. MD Michael Curry Maria Andreea Catana Imad Nasser Muhammad Mohid Tahir Aamir Ali IRs using #AI will replace those who don’t! Save time, get smarter, & become AI enhanced! Be sure to subscribe our newsletter: https://lnkd.in/gRwAjsEf Society of Interventional Oncology Beth Israel Deaconess Medical Center Beth Israel Deaconess Medical Center Transplant Institute American Society of Transplant Surgeons CVIR Oncology CVIR Endovascular Cardiovascular and Interventional Radiological Society of Europe (CIRSE) #VIR #IR #LiverCancer #RadOnc #InterventionalOncology #VIR #MedicalResearch #InterventionalRadiology #Oncology #Radiology #LiverCancer #HCC #Hepatology #LiverCancer #IR

🚨 Intranodal lymphangiography (ILAG) achieves 44% clinical success for lymphatic leaks at a median of 14 days👇 Check out the new study from @cvirendo exploring the potential of this first-line interventional technique for difficult cases Study Details: 🔍 Multicentre retrospective analysis (2017-2023) 🔍 Patients: Large volume lymphatic leaks (>500 mL/day) 🔍 ILAG performed to achieve lymphatic opacification & leak identification 🔍 Refractory cases received embolisation as adjunctive treatment Results: ✔️ ILAG success in 14/32 patients (44%) ✔️ Median time: 14 days ✔️ Embolisation for 12 refractory cases: success in 8 (67%) ✔️ Overall success of interventions: 69% ✔️ Median clinical success time: 11 days (IQR 5-34) 📌 Conclusion: In this study, ILAG achieved clinical success in 44% of cases, with embolisation providing additional benefit in refractory cases. Outcomes varied across different leakage sites & etiologies. 🔗 Full study: https://lnkd.in/e5kNCXpa What are your thoughts on this approach? Diana Velazquez-Pimentel Conrad von Stempel Jimmy Kyaw Tun Tim Fotheringham Borzoueh (Boz) Mohammadi Richard Hesketh Julian Hague Jocelyn Brookes Matthew Seager AbdulRahman Alvi Mohamed Adhnan Thaha Follow us for the latest in #VIR & subscribe to our newsletter: https://lnkd.in/gRwAjsEf CardioVascular and Interventional Radiology (CVIR) Cardiovascular and Interventional Radiological Society of Europe (CIRSE) BSIR - British Society of Interventional Radiology vRad (Virtual Radiologic) IR Juniors #iRads #InterventionalRadiology #MedicalInnovation #VIR #IR #iRad #LymphaticLeaks #InterventionalRadiology #LymphaticInterventions #Radiology

🚨 Portal Vein Recanalization with Intrahepatic Portosystemic Shunt (PVR-TIPS) led to significant symptom relief in non-cirrhotic patients with chronic portal vein occlusion (CPVO)👇 Learn about this newly published study from CardioVascular and Interventional Radiology (CVIR) on its efficacy & safety Study details: 🔍 21 non-cirrhotic patients with CPVO and portal cavernoma underwent PVR-TIPS 🔍 Focus on hemodynamic changes and clinical outcomes 🔍 Assessed through pressure gradient reduction and symptom resolution Findings: ➡️ Significant portal pressure gradient reduction by 10 mmHg (21.475 ± 9.7 mmHg to 11.454± 5.4 mmHg, p< 0.001) ➡️ Symptom resolution: - Ascites (p=0.016) - Gastroesophageal varices (p=0.004) - Abdominal pain (p=0.0021) - GI bleeding cessation (p=0.021) Safety: 📌 33% experienced complications: - 6 grade III: Perioperative liver bleeding (1), delayed stent occlusions (5) - 1 grade VI: Resulted in death (4.8%) 📌 Patency and survival: - Primary patency: 76% - Secondary patency: 100% - 90.4% survival rate 📌 Conclusion: PVR-TIPS shows promise in reducing portal hypertension symptoms with a manageable safety profile. It may serve as a valuable option in select patients and could play a role in liver transplantation strategies 🔗 Full study: https://lnkd.in/esihssSG What are your thoughts on PVR-TIPS in non-cirrhotic CPVO treatment? Fabio Ferla Fabiane Barbosa Stay ahead with #AI in #IR! Subscribe to our newsletter: https://lnkd.in/gRwAjsEf #VIR #InterventionalRadiology #InnovativeTechniques #CPVO #PortalVein #VascularHealth CVIR Endovascular

🚨 79.1% reduction in international prostate symptom score (IPSS) with transperineal prostate thermal ablation (TPTA) for BPH👇 Check out the latest study from CardioVascular and Interventional Radiology (CVIR) on this minimally invasive treatment option💡 Study Details: 🔹 25 BPH patients participated 🔹 TPTA performed using a 17G radiofrequency needle 🔹 Under unconscious sedation and local nerve blocks 🔹 Primary outcome: successful bilateral prostate ablation 🔹 Discharged within 3 hours post-procedure Results at 3-month follow-up: ✅ 79.1% reduction in IPSS ✅ 70.3% reduction in quality of life (QoL) score ✅ 36.9% decrease in prostate volume & 70.8% in intravesical prostatic protrusion (IPP) ✅ PSA levels dropped 54.7% More outcomes: ✅ Post-void residual volume decreased by 51.1% ✅ Maximum urinary flow rate (Qmax) increased by 102.3% ✅ 96% no longer required BPH medical therapy ✅ Mild complications in 24% of patients, no severe adverse events reported 📌 Conclusion: Ultrasound-guided TPTA with radiofrequency ablation demonstrates promising initial results for BPH management in outpatient settings. 🔗 Read the full study: https://lnkd.in/eWg_cxKS What are your thoughts on this new approach? Publio Viana Denis Szejnfeld Guilherme Mariotti Rafael Dahmer Rocha Vinicius Fornazari Stay ahead in #VIR by following us for the latest updates! Subscribe to our newsletter: https://lnkd.in/gRwAjsEf #InterventionalRadiology #BPH #Innovation #ProstateTreatment #MedTwitter #IRAdvances #Urology #MinimallyInvasive #BPHManagement #OutpatientCare #BPH #InterventionalRadiology #ProstateHealth CVIR Endovascular